|
|
|
Volumn 28, Issue 10, 2001, Pages 1381-1390
|
|
Late phase II study of S-1 in patients with advanced head and neck cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
OXONIC ACID;
PYRIDINE DERIVATIVE;
S 1 (COMBINATION);
TEGAFUR;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
DRUG COMBINATION;
FEMALE;
HEAD AND NECK TUMOR;
HUMAN;
LYMPH NODE METASTASIS;
MALE;
METASTASIS;
MIDDLE AGED;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
SQUAMOUS CELL CARCINOMA;
ADMINISTRATION, ORAL;
ADULT;
AGED;
ANTIMETABOLITES, ANTINEOPLASTIC;
CARCINOMA, SQUAMOUS CELL;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
FEMALE;
HEAD AND NECK NEOPLASMS;
HUMANS;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
OXONIC ACID;
PYRIDINES;
TEGAFUR;
|
|
EID: 0035489130
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (101)
|
|
References (0)
|
